The negative impact of the sanctions on the preferential supply of medicines to Russian patients was not noted. DEA News With reference to the report of the Ministry of Health of Russia on the results of studies for 2022.
The report emphasizes that the conditions created as a result of economic sanctions do not adversely affect the availability of subsidized drugs for the population.
The Ministry of Health states that the share of clinical trials of domestic drugs has increased in the country. In addition, the innovative development of the pharmaceutical market in Russia continues. Especially last year, 950 drugs were registered in the Russian Federation, 796 of which were Russian-made.
Gabriel Felbermeier, former Director of the Austrian Institute for Economic Research declarationHe said that the sanctions imposed by Western countries on Russia were not effective enough. Therefore, adding drugs to the list of sanctioned products will help increase the pressure on Moscow.